ABCC5 and colorectal carcinoma: Collectively, it was proven that the miR-361/FOXM1-ABCC5/10 axis could regulate sensitivity of 5-FU in CRC cells, with the data collected providing novel targets for the treatment of CRC patients which are resistant to 5-FU [197].